Quintiles’ central laboratory in Mumbai has received accreditation from the College of American Pathologists 15189SM Accreditation Programme, becoming the first laboratory in Asia to receive this accreditation and meet the programme’s rigorous requirements for medical laboratory quality and competence established by the International Organization for Standardization (ISO).
Thomas Wollman, Senior Vice President, Quintiles Global Laboratories said, “This accreditation is further evidence of Quintiles’ commitment to deliver high quality, harmonised test results to our biopharma customers globally. Quintiles has the world’s largest CAP-accredited central laboratory network.”
CAP 15189SM is a voluntary, non-regulatory accreditation to the ISO 15189:2007 Standard and complements CAP accreditation and other quality systems. The programme optimises processes to improve patient care, strengthens quality standards while reducing institutional errors and risks and controls costs.
CAP Council on Accreditation Chairman Richard Gomez, said, “Our goal with the CAP15189 Accreditation Programme is to improve patient care, mitigate risk, optimise performance, and advance quality for medical laboratory testing. The CAP, as it did more than 50 years ago with laboratory accreditation, is breaking new ground with our programme devoted to ISO 15189.”
Anil Raghavan, Managing Director, Quintiles India, said, “The accreditation focuses on the continuum of care directly connected with improved patient safety and risk reduction. We are proud to be the first Asia Pacific lab to receive this accreditation, which reflects our commitment to establishing best-in-class practices in the industry.”
EP News Bureau – Mumbai
